Cargando…

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease

BACKGROUND: Severe acute respiratory coronavirus 2 (SARS-CoV-2) has caused a devastating worldwide pandemic. Hydroxychloroquine (HCQ) has in vitro activity against SARS-CoV-2, but clinical data supporting HCQ for coronavirus disease 2019 (COVID-19) are limited. METHODS: This was a retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satlin, Michael J., Goyal, Parag, Magleby, Reed, Maldarelli, Grace A., Pham, Khanh, Kondo, Maiko, Schenck, Edward J., Rennert, Hanna, Westblade, Lars F., Choi, Justin J., Safford, Monika M., Gulick, Roy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377460/ https://www.ncbi.nlm.nih.gov/pubmed/32701969 http://dx.doi.org/10.1371/journal.pone.0236778

Ejemplares similares

Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
por: Pham, Khanh, et al.
Publicado: (2021)

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
por: Magleby, Reed, et al.
Publicado: (2020)

Bacterial Coinfections in Coronavirus Disease 2019
por: Westblade, Lars F., et al.
Publicado: (2021)

Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City
por: Satlin, Michael J., et al.
Publicado: (2021)

Sex-Related Differences in Clinical Presentation and Risk Factors for Mortality in Patients Hospitalized With Coronavirus Disease 2019 in New York City
por: Mathad, Jyoti S, et al.
Publicado: (2021)

Association of body mass index with morbidity in patients hospitalised with COVID-19
por: Plataki, Maria, et al.
Publicado: (2021)

Clinical Characteristics of Covid-19 in New York City
por: Goyal, Parag, et al.
Publicado: (2020)

SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19
por: Westblade, Lars F., et al.
Publicado: (2020)

Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes
por: MCCULLOUGH, S. ANDREW, et al.
Publicado: (2020)

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
por: Bansal, Pankaj, et al.
Publicado: (2020)

Antibiotic tolerance
por: Westblade, Lars F., et al.
Publicado: (2020)

Comparison of Two High-Throughput Reverse Transcription-PCR Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2
por: Craney, Arryn R., et al.
Publicado: (2020)

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021)

Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES)
por: Kennel, Peter J., et al.
Publicado: (2019)

Response by Pinheiro et al to Letter Regarding Article, “Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study”
por: Pinheiro, Laura C., et al.
Publicado: (2020)

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

Hydroxychloroquine shortage
por: Patel, J., et al.
Publicado: (2020)

154. Diagnosis and Genotyping of Coxiella burnetii Causing Endocarditis in a Patient With Prosthetic Pulmonary Valve Replacement (PVR) Using Next-Generation Sequencing (NGS) of Plasma
por: Kondo, Maiko, et al.
Publicado: (2018)

Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
por: Hile, Grace A., et al.
Publicado: (2017)

Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers
por: de Reus, Y. A., et al.
Publicado: (2022)

Meningovascular Syphilis Presenting as a Brain Mass in an Immunocompetent Male
por: Pham, Khanh, et al.
Publicado: (2021)

Corrigendum to: Meningovascular Syphilis Presenting as a Brain Mass in an Immunocompetent Male
por: Pham, Khanh, et al.
Publicado: (2022)

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
por: Sridhar, Arun R., et al.
Publicado: (2020)

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020)

Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019
por: Kim, Ji-Won, et al.
Publicado: (2022)

Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine
por: Tanaka, Tomohiro, et al.
Publicado: (2023)

Comparison of Perianal Swab and Stool Samples for Detection of Gastrointestinal Colonization with Ceftriaxone-Resistant and Fluoroquinolone-Resistant Enterobacteriaceae
por: Satlin, Michael, et al.
Publicado: (2017)

Causes and Temporal Patterns of 30‐Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction
por: Goyal, Parag, et al.
Publicado: (2018)

Assembling and validating a heart failure-free cohort from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study
por: Goyal, Parag, et al.
Publicado: (2020)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae
por: Hamm, Brandon S., et al.
Publicado: (2020)

Assessing mortality differences across acute respiratory failure management strategies in Covid-19
por: Krishnan, Jamuna K., et al.
Publicado: (2022)

Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
por: Rakedzon, Stav, et al.
Publicado: (2020)

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?
por: Ippolito, Matthew M, et al.
Publicado: (2020)

The Role of Hydroxychloroquine in Coronavirus Disease 2019. A Versatile Tool at the Service of Humanity
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
por: O'Laughlin, John P., et al.
Publicado: (2016)

Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19
por: Su, Chang, et al.
Publicado: (2021)

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
por: Ramireddy, Archana, et al.
Publicado: (2020)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine
por: Mukherjee, Aveek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_47trd147cikaf4cgk2kkjk89v6